TEAM:NASDAQAtlassian Corporation Analysis
Data as of 2026-03-11 - not real-time
$78.01
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Atlassian’s stock is trading well beneath its 20‑day moving average and the 200‑day average, with the RSI hovering in the low‑30s, suggesting an oversold condition. Technical indicators show a bullish MACD histogram despite an overall bearish trend, while volume has been tapering, adding to the downside pressure. The company’s volatility is markedly high and its beta exceeds one, indicating sensitivity to market swings. On the fundamentals side, revenue is growing at a robust 23% year‑over‑year and gross margins remain strong, yet operating and profit margins are negative, and earnings missed expectations in the latest quarter. Analysts remain optimistic, maintaining a “buy” consensus and highlighting the recent AI agents rollout in Jira as a catalyst. Valuation metrics reveal a DCF fair value north of $200 versus a market price under $80, implying a potential upside exceeding 100% and positioning the stock as deeply undervalued.
Given the pronounced price discount, the ongoing AI product development, and the strong analyst support, the upside potential is compelling, but investors must weigh the high volatility, recent earnings disappointment, and lingering profitability concerns. A cautious stance that balances the attractive valuation with the short‑term technical weakness and risk profile is advisable.
Given the pronounced price discount, the ongoing AI product development, and the strong analyst support, the upside potential is compelling, but investors must weigh the high volatility, recent earnings disappointment, and lingering profitability concerns. A cautious stance that balances the attractive valuation with the short‑term technical weakness and risk profile is advisable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below key moving averages and bearish technical trend
- Recent earnings miss and widening loss margins
- Elevated volatility and decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Substantial valuation discount to DCF fair value
- AI‑driven product enhancements expected to drive revenue growth
- Analyst consensus remains bullish despite short‑term weakness
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- High gross margins and strong recurring revenue base
- Strategic positioning in collaborative software with expanding AI capabilities
- Long‑term upside potential exceeding 100% based on fair‑value estimates
Key Metrics & Analysis
Financial Health
Revenue Growth23.30%
Profit Margin-3.28%
P/E Ratio14.2
ROE-13.47%
ROA-1.39%
Debt/Equity76.38
P/B Ratio13.0
Op. Cash Flow$1.3B
Free Cash Flow$1.5B
Industry P/E36.8
Technical Analysis
TrendBearish
RSI37.2
Support$67.85
Resistance$97.00
MA 20$79.78
MA 50$111.79
MA 200$159.38
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$208.41
Target Price$176.68
Upside/Downside126.49%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.33
Volatility74.22%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.